- Record net service revenues of $127.0 million, up 30% from second quarter
- Record EPS of $0.52, up 79% from second quarter 2007 - Second quarter operating margin of 12.7%, up 160 bp from second quarter
2007 - Record new business awards of $204 million, up 24% from second quarter
2007 - Record total business authorizations of $979 million, up 13% from Dec.
CINCINNATI, Aug. 6 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today reported record financial results for the second quarter ended June 30, 2008.
Net service revenues for the three months ended June 30, 2008, were $127.0 million, an increase of 30 percent over net service revenues of $97.8 million for the same period a year ago. Net service revenues from the June 2, 2008, acquisition of DecisionLine Clinical Research Corporation (DecisionLine Clinical Services) accounted for approximately 2 percent of the growth in net service revenues. Net income per diluted share for the second quarter 2008 was $0.52 per share, up 79 percent from net income per diluted share of $0.29 for the same period of the prior year.
Income from operations for the three months ended June 30, 2008, was $16.1 million, or 12.7 percent of net service revenues, compared to income from operations of $10.9 million, or 11.1 percent of net service revenues, for the same period of the prior year.
Net income was $7.8 million in second quarter 2008 compared to net
income of $4.3 million for second quarter 2007. Net service revenues by
|SOURCE Kendle International Inc.|
Copyright©2008 PR Newswire.
All rights reserved